Hendrix Genetics and Sofiprotéol have signed and completed an agreement in which: (a) Sofiprotéol acquires 12% of the outstanding share capital and related voting rights in Hendrix Genetics B.V. and becomes a long-term strategic shareholder, (b) formed a strategic alliance in which the parties will focus on growth and consolidation opportunities in global animal breeding and life sciences, and (c) Hendrix Genetics S.A.S. acquired France Hybrides S.A.S, a famous French swine genetics company, from Groupe Glon. It will be integrated in its swine genetics division Hypor.

Thijs Hendrix, president: “We are pleased and proud that Sofiprotéol joins our group as a long-term strategic investor. I am confident that together, we create a new platform with a new horizon in animal breeding and life sciences.”